From cannabis to COVID: Discover the power of RNA in situ hybridization
Dr. Jeremy Hirota takes us through the technology behind his translational research program for respiratory health
Dr. Jeremy Hirota takes us through the technology behind his translational research program for respiratory health
Nirsevimab is the first potential passive immunisation for infants to demonstrate sustained protection across the entire RSV season with a single dose
In two clinical trials, Evrysdi improved motor function in people living with SMA over a broad spectrum of ages and levels of disease severity, including Types 1, 2, and 3 SMA
This collaboration will allow Tecan to expand its presence for these product lines and reach a wider customer base across the academic and biotech communities
The high-throughput system enables laboratories to double or even triple their testing capacity
The partnership enables LUMICKS to expand on the implementation of the z-Movi to new immunotherapeutic settings
This powerful new solution aims to provide more accurate COVID-19 antibody detection
Join us on Tuesday, August 11, to learn about a novel serological platform used for COVID-19 testing
Join us on Monday, August 17, to discover solutions for your laboratory's SARS-CoV-2 testing
Join us on Wednesday, August 26, to learn about an alternative assay that aims to identify virus-neutralizing antibodies in as little as five hours
BLENREP is the fifth major medicine approval for GSK in 2020
Just leave a quick lab product review today for your chance to scoop one of our weekly $100 prizes
Exclusive interviews, new methods, free downloads, and much more to help you advance your work
Watch this on-demand webinar to discover how pancreatic cancer-derived organoids can be used as a predictive tool for personalized medicine
87 percent of patients in ZUMA-2 pivotal trial responded to single infusion of Tecartus
New platform provides faster identification of defects that impact device performance
The study is the first global, randomized, double-blind, placebo-controlled phase III trial investigating Actemra/RoActemra in this setting
Saphyr’s extremely sensitive structural variation detection technology will be used to analyze samples from COVID patients from dozens of clinical sites throughout North America and Europe
The ViroKey™ SARS-CoV-2 RT-PCR Test v2.0 is a probe-based reverse transcription PCR test
The NeuroSphere Digital Care offers flexible virtual care options as the COVID-19 global pandemic impacts how healthcare is administered
AccuPlex™ SARS-CoV-2 Verification Panel and Reference Material Kit are now available with full SARS-CoV-2 viral genome coverage
Based on the results, the U.S.-based trial has been stopped, including in a second cohort of patients who received a higher dose of Kevzara (800 mg)
Partnerships, products, and solutions facilitate detection, research, and vaccine development to combat the SARS-CoV-2 virus
The “triple antibody” test will provide health professionals with an accurate indication of the presence of IgA, IgM and IgG COVID-19 antibodies within 10 minutes
Establishing a broad range of remotely accessible COVID-19 assays including biochemical profiling for COVID-19 drug targets